Sign In
Get Clay Free →

Suggestions

    Helen Evans

    Senior Scientist at Triplet Therapeutics

    Professional Background

    Helen Evans is a highly motivated and accomplished scientist specializing in organic chemistry, chemical biology, and medicinal chemistry. With extensive experience in the rational design and synthesis of small molecules, peptides, and protein-based chemical probes, Helen has significantly contributed to the discovery and development of novel therapeutics and diagnostic agents. Her journey in science showcases a deep commitment to innovation and excellence in her field.

    Currently, Helen holds the prestigious position of Senior Scientist in Conjugation Chemistry at Triplet Therapeutics. In this role, she applies her specialized knowledge in organic and medicinal chemistry to develop cutting-edge therapeutic solutions that address critical health challenges. Her previous experiences include serving as Scientist I in Biochemistry at ImmunoGen, Inc., where she was involved in pioneering research that enhances therapeutic effectiveness in treating various diseases.

    Helen’s academic journey began at Imperial College London, where she earned her Doctorate in Philosophy (PhD) focusing on Synthetic Organic Chemistry and Radiochemistry. This foundational experience equipped her with a robust understanding of chemical interactions and the intricacies involved in drug design. Before her PhD, she completed her Master of Chemistry (MChem) at the University of Reading, graduating with first-class honors, and began her educational path at the Coleshill School, laying the groundwork for her scientific career.

    Her work and research contributions have garnered respect and recognition within the scientific community, further evidenced by her prestigious postdoctoral fellowships at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) and Harvard University. At MIT, she was not only a postdoctoral fellow but also held roles as a postdoctoral associate, contributing to innovative cancer research that has the potential to change treatment modalities. Helen's tenure at Harvard University also shows her versatility and dedication, working in an environment renowned for its high standards in both research and scientific output.

    Additionally, Helen's journey includes a pivotal industrial placement at GlaxoSmithKline, where she gained valuable insights into the pharmaceutical industry and strengthening her skills in practical chemistry applications. Her early training during her PhD studentship at Imperial College further enriched her knowledge and research acumen.

    Education and Achievements

    Helen's extensive education has played a crucial role in her professional journey. She completed her Doctor of Philosophy (PhD) in Synthetic Organic Chemistry and Radiochemistry at the esteemed Imperial College London. Here, she honed her research skills and developed innovative methodologies critical for understanding complex chemical processes.

    Before attaining her PhD, Helen’s commitment to chemistry was evident during her studies at the University of Reading, where she earned her MChem with first-class honors. This distinction reflects not just her academic capability but also a passionate pursuit of knowledge in chemistry. Her background at Coleshill School set a solid foundation in the sciences, leading her to excel in her higher education pursuits.

    Helen’s remarkable achievements extend beyond her education, reflected in her various research positions and the impactful work she continues to undertake within the field. Her role at Triplet Therapeutics sees her at the forefront of scientific advancements, particularly in therapeutic development, demonstrating a blend of both leadership and collaborative skills in a fast-paced environment.

    Achievements

    Throughout her distinguished career, Helen Evans has made significant strides in the realms of organic chemistry and medicinal chemistry. Her role as Senior Scientist in Conjugation Chemistry at Triplet Therapeutics signifies her qualifications and expertise, allowing her to lead projects that aim to enhance drug efficacy and safety.

    Helen’s previously held positions at ImmunoGen, Inc., and her postdoctoral roles—including those at MIT and Harvard—stand as a testament to her research capabilities and contributions to advancing cancer therapies. Her strong background in rational design and synthesis of chemical probes has allowed her to partake in groundbreaking research that directs the future of medical science.

    In addition to her professional achievements, Helen's commitment to ongoing learning and development is indicative of her character as a dedicated scientist. She continuously seeks opportunities to expand her knowledge base and improve her skills, ensuring that she remains at the forefront of her field.

    In summary, Helen Evans epitomizes passion and excellence in the scientific community. With her rich background in organic and medicinal chemistry, impressive educational qualifications, and an extensive career at leading organizations, she is poised to make substantial contributions to the fields of therapeutics and diagnostics, enhancing patient care and treatment outcomes globally.

    Related Questions

    How did Helen Evans develop her expertise in organic chemistry?
    What are some of the notable projects Helen Evans has led at Triplet Therapeutics?
    How has Helen's education at Imperial College London shaped her career in medicinal chemistry?
    In what ways has Helen's experience at leading institutions like MIT and Harvard influenced her research approach?
    What contributions has Helen made to the field of drug discovery and development?
    How does Helen Evans stay updated with the latest advancements in chemical biology and organic chemistry?
    In what ways does Helen collaborate with other scientists in her current role?
    Helen Evans
    Add to my network

    Location

    Greater Boston Area